Recursion Pharmaceuticals (RXRX) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by the CEO and Chair, with all board members and key executives present, including representatives from the independent public accountants and Inspector of Elections.

• Agenda and rules of conduct were posted online, with voting on three proposals as the main business, followed by a Q&A session for validated stockholders.

Board and executive committee updates

• Notice of meeting and proxy materials were distributed to all stockholders of record as of April 21, 2026.

• Quorum was confirmed, allowing the meeting to proceed.

Shareholder proposals

• Three proposals were presented: election of two Class II directors for a three-year term, advisory vote on executive compensation, and ratification of the independent public accounting firm.

• Board recommended voting in favor of all proposals.